An Optimized DEC Prediction Model Was Not the Same Test as an Officer’s Drug Opinion

A statistical model optimized from DEC observations is not the same assessment as an officer’s actual drug opinion. A laboratory study reported results for both, and their distinction matters when evaluating claims about identifying marijuana-related effects.

Two procedures used the same experimental setting

Heishman and colleagues studied 18 volunteers in nine randomized, double-blind sessions involving ethanol, cocaine, marijuana and placebo conditions. They examined a broad set of evaluation observations and compared officers’ judgments with toxicology.

The report also developed optimized prediction models using selected combinations of variables. Those models involved 17 to 28 variables. A fitted combination can use information differently from the decision process an examiner actually applied.

Do not transfer model performance to officers

The reported consistency of officers’ non-ethanol drug opinions with toxicology was 44%. That figure covered the study’s non-ethanol conditions; it was not a cannabis-specific impairment sensitivity estimate.

An optimized model’s result cannot replace that observed judgment result unless the model is actually the procedure under evaluation. Claims about deployment additionally need evidence that the specified model works on appropriate data beyond the observations used to select it.

Ask which rule produced the conclusion

A review should identify whether a quoted result belongs to a fitted equation, a predefined scoring rule or an examiner’s opinion. Those procedures can share inputs while producing different classifications and errors.

Toxicology agreement also addresses drug exposure rather than directly measuring driving ability. This controlled study helps separate these methodological questions; it does not supply a universal numerical accuracy rate for every contemporary marijuana examination.

Related: How the reference specimen changes a cannabis accuracy claim.

Research cited

Heishman SJ; Singleton EG; Crouch DJ; Journal of Analytical Toxicology; 1996. Laboratory Validation Study of Drug Evaluation and Classification Program: Ethanol, Cocaine, and Marijuana.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

An Open-Label CBD Dose-Escalation Study Could Not Establish Placebo-Adjusted Motor Benefit

A small open-label CBD dose-escalation study in Parkinson’s disease reported improved motor scores and frequent mild adverse effects. Those observations inform feasibility and tolerability, but do not establish how much improvement CBD produced beyond placebo or other influences. Escalation and completion were part of the design The review describes Leehey…

Spread the love

Read Article: An Open-Label CBD Dose-Escalation Study Could Not Establish Placebo-Adjusted Motor Benefit

An Isolated Naming Improvement Was Not a Global Cognitive Benefit in a CBD Trial

An improvement in one naming subdomain did not establish a general cognitive benefit in a Parkinson’s trial summarized by a review. Most other clinical and cognitive findings did not show the same favorable pattern. The preparation and population were specific The review describes Mitarnun and colleagues’ placebo-controlled trial of a…

Spread the love

Read Article: An Isolated Naming Improvement Was Not a Global Cognitive Benefit in a CBD Trial

Preserved Dopamine Neurons Did Not Mean Every Motor Test Improved After CBD

A CBD rat study summarized in a review reported neuronal protection and improvement in selected motor measures, with limited improvement on other tests. A tissue finding should therefore not be substituted for a universal functional benefit. The lesion model assessed several domains The review describes Giuliano and colleagues’ work in…

Spread the love

Read Article: Preserved Dopamine Neurons Did Not Mean Every Motor Test Improved After CBD

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us